Skip to content Skip to sidebar Skip to footer

Expert Review of Pharmacoeconomics & Outcomes Research Author Guidelines


Proficient Review of Pharmacoeconomics and Outcomes Research - Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on November 16, 2021


Note: The touch score shown here is equivalent to the average number of times documents published in a journal/conference in the by ii years accept been cited in the current year (i.eastward., Cites / Doc. (ii years)). It is based on Scopus data and can be a fiddling higher or different compared to the impact gene (IF) produced past Journal Commendation Report. Please refer to the Spider web of Scientific discipline information source to bank check the exact journal impact factor ™ (Thomson Reuters) metric.

Of import Metrics

Title Practiced Review of Pharmacoeconomics and Outcomes Research
Abbreviation Adept Rev. Pharmacoeconomics Outcomes Res.
Publication Blazon Journal
Field of study, Categories, Scope Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)
h-index 49
Overall Rank/Ranking 7462
SCImago Journal Rank (SJR) 0.67
Impact Score 1.86
Publisher Taylor and Francis Ltd.
Country Uk
ISSN 14737167, 17448379


About Proficient Review of Pharmacoeconomics and Outcomes Research


Expert Review of Pharmacoeconomics and Outcomes Inquiry is a journal covering the technologies/fields/categories related to Wellness Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published past Taylor and Francis Ltd.. The overall rank of Expert Review of Pharmacoeconomics and Outcomes Enquiry is 7462. According to SCImago Journal Rank (SJR), this journal is ranked 0.67. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come up. SJR acts equally an alternative to the Journal Touch on Gene (or an average number of citations received in last 2 years). This journal has an h-alphabetize of 49. The best quartile for this journal is Q2.

The ISSN of Good Review of Pharmacoeconomics and Outcomes Research journal is 14737167, 17448379. An International Standard Serial Number (ISSN) is a unique code of viii digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be information technology print-media or electronic. Good Review of Pharmacoeconomics and Outcomes Research is cited by a total of 427 articles during the last three years (Preceding 2020).


Expert Review of Pharmacoeconomics and Outcomes Enquiry Bear upon Score 2020-2021


The impact score (IS) 2022 of Expert Review of Pharmacoeconomics and Outcomes Inquiry is 1.86, which is computed in 2022 equally per its definition. Skilful Review of Pharmacoeconomics and Outcomes Research IS is decreased past a factor of 0.nineteen and approximate percentage change is -ix.27% when compared to preceding year 2019, which shows a falling tendency. The bear on score (IS), also denoted equally Journal affect score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus information.

Table Setting


Skilful Review of Pharmacoeconomics and Outcomes Enquiry Impact Score 2022 Prediction


IS 2022 of Expert Review of Pharmacoeconomics and Outcomes Inquiry is one.86. If the aforementioned downwardly trend persists, impact score of joule may fall in 2022 every bit well.


Bear upon Score Trend


Yr wise Impact Score (IS) of Expert Review of Pharmacoeconomics and Outcomes Enquiry. Based on Scopus data.

Twelvemonth Touch on Score (IS)
2021/2022 Coming Soon
2020 one.86
2019 ii.05
2018 1.64
2017 1.61
2016 1.58
2015 ane.75
2014 1.95

Practiced Review of Pharmacoeconomics and Outcomes Research h-alphabetize


Table Setting

Proficient Review of Pharmacoeconomics and Outcomes Enquiry has an h-index of 49. It means 49 articles of this journal have more 49 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.


Expert Review of Pharmacoeconomics and Outcomes Research ISSN


The ISSN of Expert Review of Pharmacoeconomics and Outcomes Research is 14737167, 17448379. ISSN stands for International Standard Serial Number.

An ISSN is a unique lawmaking of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it impress-media or electronic.

Table Setting


Expert Review of Pharmacoeconomics and Outcomes Inquiry Rank and SCImago Journal Rank (SJR)


The overall rank of Expert Review of Pharmacoeconomics and Outcomes Enquiry is 7462. According to SCImago Journal Rank (SJR), this journal is ranked 0.67. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Practiced Review of Pharmacoeconomics and Outcomes Research Publisher


Table Setting

Expert Review of Pharmacoeconomics and Outcomes Research is published by Taylor and Francis Ltd.. It's publishing house is located in U.k.. Coverage history of this periodical is as post-obit: 2001-2020. The organisation or private who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the farther details about the phone call for papers.


Abbreviation


The IS0 4 standard abbreviation of Expert Review of Pharmacoeconomics and Outcomes Enquiry is Expert Rev. Pharmacoeconomics Outcomes Res.. This abbreviation ('Practiced Rev. Pharmacoeconomics Outcomes Res.') is well recommended and canonical for the purpose of indexing, abstraction, referencing and citing goals. Information technology meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent organisation for abbreviating serial publication titles and journals.


How to publish in Expert Review of Pharmacoeconomics and Outcomes Research


If your research field is/are related to Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Charge per unit


The credence rate/per centum of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed beneath.

  • The demand or interest of researchers/scientists in publishing in a specific Periodical/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time information technology takes from manuscript submission to final publication.
  • And Many More.

Information technology is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate ciphering. On the other mitt, few consider the only manuscripts sent for peer review or few even not carp about the accurate maintenance of total submissions. Hence, information technology tin provide a crude estimation simply.

The all-time style to detect out the acceptance rate is to attain out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Periodical & Country Rank (SJR), https://www.scimagojr.com/
  • Periodical Impact Factor, https://clarivate.com/


montgomeryyourty.blogspot.com

Source: https://www.resurchify.com/impact/details/21371

Post a Comment for "Expert Review of Pharmacoeconomics & Outcomes Research Author Guidelines"